Drug profile · INN
enoxaparin sodium
INHIXA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
enoxaparin sodium (INHIXA) is an FDA-listed pharmaceutical active ingredient. Associated with Amphastar France Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN enoxaparin sodium
Brand INHIXA
Route INJECTION
Formulation INJECTABLE
ATC code B01AB05
Originator Amphastar France Pharmaceuticals
Frequently asked questions
What is enoxaparin sodium?
enoxaparin sodium (INHIXA) is an FDA-listed pharmaceutical active ingredient. Associated with Amphastar France Pharmaceuticals. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for enoxaparin sodium?
INHIXA is a marketed brand name for enoxaparin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of enoxaparin sodium?
enoxaparin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.